# Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers

> **NCT01027182** · PHASE1 · COMPLETED · sponsor: **Changi General Hospital** · enrollment: 6 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT01027182
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2010-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01027182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01027182, "Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01027182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*